Another posts

fob chain definition crown princess definition death toll definition frat house definition tickly definition enterics definition jew's harp definition define morne the rock of gibraltar meaning untrustworthiness definition learnable definition gallant steed full swing meaning acclivitous definition switzer definition hypothetical etymology eating me out of house and home waverer definition nigger-heads coaction definition mouth organ definition crack shot definition reptilia examples conciergerie definition prop roots definition new world fly catcher overt examples imperceivable definition another word for hollow bread buttered on both sides percipient definition

plasminogen

Definitions

  • WordNet 3.6
    • n plasminogen an inactive form of plasmin that occurs in plasma and is converted to plasmin by organic solvents
    • ***

Usage


In news:

Studies Provide Structural Insights on Activation, Conversion of Plasminogen to Plasmin.
Approval of recombinant tissue plasminogen activator (alteplase) as an intravenous thrombolytic therapy is currently limited to a 3 h time window after stroke onset.
Studies Provide Structural Insights on Activation, Conversion of Plasminogen to Plasmin .
Studies Provide Structural Insights on Activation, Conversion of Plasminogen to Plasmin.
Administering a clot-dissolving experimental drug known as TPA (tissue plasminogen activator) directly into the brain may help to stop a stroke in progress, according to Phillip A Scott, M.D.
***

In science:

Clark W. M., Wissman S., Albers G. W., Jhamandas J. H., Madden K. P. and Hamilton S. (1999) Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset.
Post-ischaemic treatment with the cyclooxygenase-2 inhibitor nimesulide reduces blood-brain barrier disruption and leukocyte infiltration following transient focal cerebral ischaemia in rats
Pharmacol. 330 (1997) 221-229. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, Tissue plasminogen activator for acute ischemic stroke, New England J.
Wide therapeutic time window for nimesulide neuroprotection in a model of transient focal cerebral ischemia in the rat
Postischemic (6-Hour) treatment with recombinant human tissue plasminogen activator and proteasome inhibitor PS-519 reduces infarction in a rat model of embolic focal cerebral ischemia.
Neuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemia
***